EGFR and head and neck squamous cell carcinoma: Considering the strong EGFR upregulation in the UMSCC lines [29], and the adoption of Cetuximab (CTX) as the standard of care for the treatment of HNSCC [20, 21], we preliminarily tested the cytotoxic effect of this drug in UMSCC 103 (Fig. 1c).